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ABSTRACT We have synthesized, separated, and purified
=10 mg of a deoxyundecanucleotide duplex containing a single
centrally positioned covalent adduct between (+)-anti-
benzo[a]pyrene (BP) diol epoxide and the exocyclic amino
group of guanosine. Excellent proton NMR spectra are ob-
served for the (+)-trans-anti-BP diol epoxide-N2-dG adduct
positioned opposite dC and flanked by G-C pairs in the
d[Cl-C2-A3-T4-C5-(BP)G6-C7-T8-A9-C10-C1l]d[G12-G13-
T14-A15-G16-C17-G18-Al9-T20-G21-G221 duplex [designat-
ed (BP)G-C li-mer]. We have determined the solution struc-
ture centered about the BP covalent adduct site in the (BP)G-C
ll-mer duplex by incorporating intramolecular and intermo-
lecular proton-proton distance bounds deduced from theNMR
data sets as constraints in energy minimization computations.
The BP ring is positioned in the minor groove and directed
toward the 5' end of the modified strand. One face of the BP
ring of (BP)G6 is stacked over the G18 and A19 sugar-
phosphate backbone on the partner strand and the other face
is exposed to solvent. A minimally perturbed B-DNA helix is
observed for the d[T4-C5-(BP)G6-C7-T8]Jd[A15-G16-C17-
G18-A19] segment centered about the adduct site with Watson-
Crick alignment for both the (BP)G6-C17 pair and flanking
GC pairs. A widening of the minor groove at the adduct site
is detected that accommodates the BP ring whose long axis
makes an angle of =45° with the average direction of the DNA
helix axis. Our study holds future promise for the character-
ization of other stereoisomerically pure adducts of BP diol
epoxides with DNA to elucidate the molecular basis of struc-
ture-activity relationships associated with the stereoisomer-
dependent spectrum of mutational and carcinogenic activities.
Benzo[a]pyrene (BP), a ubiquitous environmental pollutant,
is metabolized in mammalian cells to highly reactive, muta-
genic, and tumorigenic diol epoxide derivatives (the field of
carcinogen-DNA adducts is reviewed in refs. 1-3). Their
binding to cellular DNA is known to cause mutations (3),
including the transformation ofprotooncogenes to oncogenes
(4-6). It is widely believed that mutations can constitute the
initial first steps in the complex multistage phenomenon of
chemical carcinogenesis (7-10). There are two diastereoiso-
mers of the biologically most important bay region BP diol
epoxides (BPDEs), and each of these can be resolved into a
pair of enantiomers (11). Of the four stereoisomers, only the
(+)-anti-isomer 7p8,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-
tetrahydrobenzo[a]pyrene [(+)-anti-BPDE; structure 1] is
highly tumorigenic (12, 13). Furthermore, it has been shown
that racemic anti-BPDE is mutagenic in mammalian cells,
with the (+)-anti-BPDE isomer inferred to be significantly
more mutagenic than the (-)-anti-BPDE isomer per DNA
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adduct formed (14-17). These fascinating differences provide
an excellent opportunity for examining the molecular basis of
the relationships between DNA adduct structure and biolog-
ical activity, since only the stereochemical properties ofthese
BPDE compounds are different. Some of the characteristics
of BPDE adducts with DNA have been characterized by
low-resolution optical spectroscopic techniques (for review,
see refs. 18-20).
When reacted with native DNA, (+)-anti-BPDE is known
to bind predominantly to the exocyclic amino group of
deoxyguanosine by trans-addition at the carbon-10 position
(21-23). Using methods as described (24, 25), but starting
with racemic anti-BPDE, we have synthesized =5 mg of the
stereochemically pure BPDE-oligonucleotide adduct 5'-d[C-
C-A-T-C-(BP)G-C-T-A-C-C] where (BP)G denotes the (+)-
trans-anti-BPDE-N2-dG adduct (structure 2). The modified
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strand was annealed to its complementary partner strand to
generate the (BP)G-C 11-mer duplex (structure 3), which
BPDE
5'- C1-C2-A3-T4-C5-G6-C7-T8-A9-Clo--Cl1 -3'
3'- G22-G21-T20-A19-G18-C17-G16-Al5-T14-G13-G12 -5'
Structure 3
Abbreviations: BP, benzo[a]pyrene; BPDE, BP diol epoxide; NOE,
nuclear Overhauser effect; NOESY, NOE spectroscopy.
IlTo whom reprint requests should be addressed.
1914
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Biochemitry:Cosmanal.Proc. Nati. Acad. Sci. USA 89 (1992) 1915
contains enantiomerically pure (+)-trans-anti-(BP)G6 posi-
tioned opposite C17 and flanked by G-C pairs. The NMR
study was undertaken on 9.6 mg of(BP)G&C 1i-mer duplex in
0.4 ml of 0.1 M NaCl/10 mM sodium phosphate, pH 7.0, in
H20 and 2H20. We have combined two-dimensional NMR
experiments with computational calculations to define the
solution conformation centered about the (BP)G6&C17 mod-
ification site in the (BP)G-C 1i-mer duplex.
MATERIALS AND METHODS
Preparation of (BP)G-C li-mer Duplex. The racemic anti-
BPDE was purchased from the National Cancer Institute
Chemical Carcinogen Reference Standard Repository. The
yield of the (+)-trans-anti-BPDE-N2-dG li-mer was 15%
starting from racemic anti-BPDE. The percentage ratios of
(+)-trans, (-)-trans, (+)-cis, and (-)-cis adducts in the
mixture were 48, 33, 10, and 9%, respectively. The (+)-trans-
anti-BPDE-N2-dG li-mer adduct was easily separable from
the corresponding (-)-trans, (+)-cis, and (-)-cis isomeric
adducts by preparative HPLC on a C18 ODS Hypersil column
using a linear 0-90% (vol/vol) methanol/20 mM sodium
phosphate, pH 7.0, gradient over a 60-min period as de-
scribed (24). The nature of the BPDE modification was
established by enzyme digestion of the modified oligonucle-
otide to the mononucleoside level and by comparing the
HPLC elution times with those of a (+)-trans-anti-BPDE-dG
standard. The enzyme digestion studies were carried out with
snake venom phosphodiesterase and bacterial alkaline phos-
phatase. The ratio of C/G/T/A/(BP)G for the modified
strand was determined to be 6.0:0:2.2:1.9:0.9. The CD spec-
tra of the modified oligonucleotide and of the adduct isolated
from this oligonucleotide are fully consistent with those ofthe
(+)-trans-anti-BPDE-N2-dG adduct standard (26). The mod-
ified strand was added to the unmodified strand at 650C and
the stoichiometry was followed by monitoring single-proton
resolved resonances in both strands.
NMR Measurements. Two-dimensional nuclear Over-
hauser effect spectroscopy (NOESY) spectra on the (BP)G-C
il-mer duplex in 2H20 buffer at 250C were recorded at mixing
times of 50, 100, 150 and 200 msec. The volume integrals of
cross peaks as a function of mixing times were measured to
generate the buildup curves. The estimated proton-proton
distances were defined by lower and upper bounds using the
fixed cytidine H6-H5 2.45-A separation as the reference
distance. As examples, the estimated distance bounds were
2.8-4.8 A for BP(H11)-G18(H1') and 2.9-4.5 A for BP(H1)-
G6(H1').
Two-dimensional correlation spectra on the (BP)G-C 11-
mer duplex were recorded in 2H20 buffer at 250C and include
phase-sensitive correlated spectroscopy, double-quantum-
filtered correlated spectroscopy, and homonuclear Hart-
mann-Hahn (as a function of spin-lock time) spectra. These
experimental through-bond two-dimensional data sets and
their simulated counterparts were critical in the assignment of
the protons on the BP ring in the (BP)G-C il-mer duplex.
NMR parameters can be used to distinguish between
B-DNA and A-DNA helical conformations (27, 28). The
nuclear Overhauser effects (NOEs) between the base proton
and its own H2' proton and the H2" proton of the 5'-flanking
sugar are strong for B-DNA. The NOEs between the base
proton and its own H3' proton and the H2' proton of the
5'-flanking sugar are strong for A-DNA. The J(1'-2') vicinal
coupling is large for the C2'-endo sugar characteristic of
B-DNA and small for the C3'-endo sugar characteristic of
A-DNA. The reverse is true for J(2"-3') and J(3'-4') vicinal
couplings. These parameters were used in a qualitative
manner to distinguish between A- and B-DNA helical con-
formations for the (BP)G-C li-mer duplex.
Energy Minimization Computations. DUPLEX is a molecular
mechanics program for nucleic acids that performs potential
energy minimizations in the reduced variable domain of
torsion angle space (29). The vast diminution in the number
of variables that must be simultaneously optimized, com-
pared to Cartesian space minimizations, permits large move-
ments from a given starting conformation during minimiza-
tion. It has the option to include distance contraints through
penalty functions to compute structures that are minimum
energy conformations (30). Details of the force fields and
parametrization are given in ref. 29. Details about the func-
tions employed to search for structures within the NMR-
defined distance bounds are given in ref. 31. The penalty
functions are released in terminal minimizations to yield
unconstrained structures that are energy minima and within
the range of the NMR data.
We briefly summarize the search and build procedure as
described (32), which was used to generate the energy-
minimized structure of the (BP)dG positioned opposite dC in
a DNA oligomer duplex. The search began with a modified
deoxydinucleoside monophosphate. About 4000 trials were
made to survey conformational space. Low-energy confor-
mations from this search were directly embedded in the
B-form d(G-C)6d(G-C)6 12-mer duplex with energy minimi-
zation. Alternately, the dinucleotide conformations were
extended to the trinucleotide level with extensive conforma-
tional searches for the added residue after which the trimers
were embedded in the B-DNA 12-mer duplexes. Details are
given in ref. 32. The alternate hydrogen-bonding scheme of
the Hoogsteen type at the modification site, which places the
carcinogen in the major groove, was also explored, as were
possibilities for denaturation at and adjacent to the adduct
site. The starting conformation of the (BP)G-C li-mer duplex
was obtained by base sequence and length adjustment of the
lowest energy structure for the (+)-trans-anti-BPDE-N2-dG
adduct in the alternating d(G-C)6gd(G-C)6 12-mer duplex. The
energy minimization computations to deduce the solution
structure of the (BP)G-C li-mer duplex were based on this
starting structure and were guided by the available experi-
mental interproton distances defined by lower and upper
bounds that were constrained within the limits using penalty
functions.
RESULTS
Exchangeable Proton Spectra. The proton NMR spectrum
of the (BP)G-C il-mer duplex in H20 buffer at 50C is plotted
in Fig. 1A. The observed pattern of narrow and resolved
imino protons (12.0-14.0 ppm) and the base and amino
protons (7.0-9.0 ppm) establish formation of a single confor-
mation for the (+)-trans-anti-(BP)G6 adduct in the duplex.
Expanded regions of the NOESY contour plot (mixing time,
200 msec) of the (BP)G-C li-mer duplex in H20 buffer at 50C
are plotted in Fig. 1B. The NOE cross peaks in these contour
plots were analyzed by standard procedures (for review, see
refs. 27 and 28) and yielded imino proton assignments in-
cluding those of (BP)G6 (12.47 ppm) at the modification site,
as well as G16 and G18 of flanking G&C pairs. NOEs between
guanosine imino and cytidine amino protons are character-
istic of Watson-Crick G*C base pairs (Fig. 1B, boxed region
II), and NOEs between thymidine imino and adenosine H2
protons are characteristic of Watson-Crick A-T base pairs
(Fig. 1B, boxed region I). The observed NOE patterns
establish Watson-Crick pairing at all G-C and A-T pairs, as
well as the (BP)G6 C17 pair in the (BP)G-C li-mer duplex.
The N2-amino proton of (BP)G6 resonates at 8.12 ppm and its
down-field shift requires hydrogen-bond participation in the
(BP)G6 C17 pair. Chemical-shift ranges for related cytidine
amino protons are 8.0-8.5 ppm for the hydrogen-bonded
Biochemistry: Cosman et al.
1916 Biochemistry: Cosman et al.
I B 0
*
, 0 .p0 1
14.0 13.0 12.0
I*
I
8.0 7.0
,J
8.0 7.2
A
12.8
13.6
FIG. 1. (A) Proton NMR spectrum (12.0-14.0 ppm and 7.0-9.0
ppm) of the (BP)G-C 11-mer duplex in 0.1 M NaCi/10 mM sodium
phosphate, pH 7.0, in H20 at 50C. The guanosine imino proton
assignments for the (BP)G6.C17 modification site and flanking
C5<G18 and C7{G16 base pairs are assigned over the spectrum. (B)
Expanded NOESY (mixing time, 200 msec) contour plot establishing
distance connectivities in the symmetrical 12.0- to 14.0-ppm imino
proton region (Left) and between the imino protons and the 7.0- to
9.0-ppm base and amino proton region (Right). The boxed region II
shows NOE cross peaks between thymidine imino protons and
adenosine H2 protons in Watson-Crick A-T base pairs, and boxed
region I shows cross peaks between guanosine imino protons and
hydrogen-bonded cytidine amino protons in Watson-Crick G&C base
pairs. The cross peaks A to D are assigned as follows: A, (BP)
G6(imino)-G16(imino); B, (BP)G6(imino)-G18(imino); C,
(BP)G6(imino)-C17(amino); D, (BP)G6(imino)-(BP)G6(amino).
proton and 6.5-7.0 ppm for the exposed proton in a G-C
Watson-Crick base pair.
Nonexchangeable Proton Spectra. The proton NMR spec-
trum of the (BP)G*C 11-mer duplex in 2H20 buffer at 250C is
plotted in Fig. 2A. The available resolution in the base proton
(6.9-8.6 ppm) and sugar Hi' (5.3-6.5 ppm) regions permits
resonance assignments using standard through-space and
through-bond two-dimensional NMR experiments (33). An
expanded NOESY (mixing time, 300 msec) contour plot
establishing NOE connectivities between the base and sugar
protons in the (BP)G-C 11-mer duplex in 2H20 buffer at 25°C
is plotted in Fig. 2B. The data are of sufficient quality to
completely assign the base and sugar (except superpositioned
H5',H5") protons of all 22 nucleotides in the (BP)G-C 11-mer
duplex. The characteristic NOE patterns between the base
protons and their own and 5'-flanking sugar Hi' protons for
a right-handed duplex (33) are traced for the [T4-C5-(BP)G6-
C7-T81][A15-G16-C17-G18-A19] central 5-base-pair segment
in Fig. 2B. The unusually large upfield shift for the Hi' proton
of G18 (3.56 ppm) and the smaller upfield shift for A19 (5.14
ppm), along with a similar trend for other protons on these
residues (see Fig. 2) requires that the BP ring covalently
attached to the G6 modification site stacks predominantly
over the sugars of G18 and to a somewhat lesser extent A19
on the partner strand. These results position the BP ring in the
minor groove with its long axis directed toward the 5' end of
the modified strand. The sugar rings in the (BP)G C 11-mer
adopt predominantly C2'-endo puckers based on a qualitative
analysis of NOE and coupling constant patterns.
The BP protons on both the aromatic and nonplanar rings
at the (BP)G6 modification site have been assigned in the
(BP)G-C 11-mer duplex based on a comparison between
experimental and calculated coupling constant patterns and
patterns of NOEs between BP protons.
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FIG. 2. (A) Proton NMR spectrum (6.9-8.6 ppm and 3.4-6.5
ppm) of the (BP)G-C 11-mer duplex in 0.1 M NaCl/10 mM sodium
phosphate, pH 7.0, in 2H20 at 25°C. (B) Expanded NOESY (mixing
time, 300 msec) contour plot establishing distance connectivities
between the 6.9- to 8.6-ppm base protons and the 3.4- to 6.5-ppm
sugar protons. The solid line traces the distance connectivities
between the base protons and its own and 5'-flanking sugar Hi'
protons in the T4-C5-(BP)G6-C7-T8 segment in the modified strand,
and the dashed line follows the connectivities in the A15-G16-C17-
G18-A19 segment in the unmodified strand. The BP aromatic protons
resonate between 8.1 and 8.5 ppm, and the aliphatic protons resonate
between 4.4 and 6.2 ppm. The resonance assignments are based on
a comparison between experimental and calculated phase-sensitive
and double-quantum-filtered correlated spectroscopy coupling pat-
terns, as well as patterns ofNOEs between BP protons. The spectral
assignments are as follows: BP(H1,H3), 8.33 ppm; BP(H2), 8.13
ppm; BP(H4,H5), 8.22 ppm; BP(H6), 8.40 ppm; BP(H7), 4.99 ppm;
BP(H8),4.48 ppm; BP(H9),4.41 ppm; BP(H1O), 6.20 ppm; BP(H11),
8.51 ppm; BP(H12), 8.23 ppm. The upfield chemical shift difference
on proceeding from the control G-C 11-mer to the (BP)G-C 11-mer for
protons on G18 are as follows: H8, 0.65 ppm; Hl', 2.05 ppm; H2',
1.08 ppm; H2", 1.87 ppm; H3', 0.68 ppm; H4', 0.77 ppm. For protons
on A19 the values are as follows: H8, 0.80 ppm; Hi', 1.04 ppm; H2',
0.39 ppm; H2", 0.68 ppm; H3', 0.64 ppm; H4', 0.79 ppm.
Intermolecular NOEs in (BP)G-C ll-mer Duplex. We have
identified and assigned the intermolecular NOEs between the
BP and nucleic acid protons in the (BP)G-C li-mer duplex.
These fall into two categories and involve 6 NOEs between
the BP aromatic protons and minor groove sugar protons on
the G18-A19 segment on the unmodified strand (several of
these are shown in Fig. 3A) and 11 NOEs between the BP
aliphatic protons and the minor groove sugar protons on the
(BP)G6-C7 segment on the modified strand (several of these
are shown in Fig. 3 B and C). These intermolecular distance
connectivities independently establish that the BP ring is
positioned in the minor groove, is directed toward the 5' end
of the modified strand, and stacks over the A18-G19 sugar-
phosphate backbone on the unmodified strand.
Eneray Inuion Computatioins. The solution structure of
the (BP)GC li-mer duplex was deduced by incorporating pro-
ton-proton distance constraints obtained from NOE. buildup
curves in constrained energy minimization calculations using the
DUPLEX program (29). The starting conformation ofthe (BP)G-C
11-mer duplex was obtained by base sequence and length ad-
justment of a (+)-1rans-anti-BPDE-N2_dG adduct in a DNA
oligomer deduced from an extensive conformational search with
no input experimental constraints (32). A set of NMR-based
interproton distances defined by lower and upper bounds be-
tween BP protons, between nucleic acid protons, and between
BP and nucleic acid protons were constrained within the limits,
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FIG. 3. Expanded NOESY (mixing time, 300 msec) contour plots
establishing distance connectivities between the 3.5- to 4.1-ppm and
8.1- to 8.5-ppm regions (A), between the 4.1- to 4.6-ppm and 5.9- to
6.5-ppm regions (B), and between the 5.9- to 6.2-ppm and 5.9- to
6.5-ppm regions (C) in the (BP)G-C li-mer duplex in 0.1 M NaCI/10
mM sodium phosphate, pH 7.0/2H20 at 250C. The cross peaks A to
F are assigned as follows: A, BP(H6)-G18(H4'); B, BP(H1/H3)-
A19(H4'); C, BP(H4/H5)-G18/A19(H4'); D, BP(H2)-A19(H4'); E,
BP(H6)-G18(H5'/H5"); F, BP(H4/H5)-G18(H5'/H5"). The cross
peaks G to K are assigned as follows: G, BP(H9)-G6(H1'); H,
BP(H9)-C7(H1'); I, BP(H8)-C7(H1'); J, BP(H1O)-C7(H1'); K,
BP(H10)-G6(H1').
using penalty functions (30, 31) during the energy minimization.
The parameters used in the current constrained energy minimi-
zation guided by distance bounds are the same as those reported
in earlier computations with no experimental input (32). The
saturated ring of BP was fixed during the constrained energy
minimization with the hydroxyl groups in the 7,8-diequatorial-
9,10iaxial conformation reported previously in the crystal
structure of the BP tetrol model compound (34) and also ob-
served for (+)-trans-anti-BPDE-N2-dG nucleoside adducts by
NMR analysis in solution (26). The observed vicinal coupling
constants between the H7 and H8 and between the H9 and 110
protons, as well as 10 NOEs between the aromatic and aliphatic
protons, are consistent with this pucker family for the nonplanar
ring of BP in the (BP)G-C il-mer duplex. The structure of the
(BP)GC il-mer duplex that satisfied the experimental distance
constraints was achieved after a single round of energy minimi-
zation to convergence. The rms deviation between the starting
structure and the constrained energy minimized structure was
0.68 A for the central d[T4-C54BP)G6-C7-T8]-d[A15-Gl6-C17-
G18-A19] 5-base-pair segment of the (BP)GC il-mer duplex.
Release of all constraints yielded a very similar structure, with
rms deviation from the constrained structure of 0.41 A. Prelim-
inary studies establish that starting structures that differ by 450 in
the torsion angles at each ofthe two bonds at the carcinogen-base
linkage site converge to the same final structure after energy
minimization guided by the experimental distance bounds.
Solution Structure. Four views of the computed structure
for the d[T4-C5-(BP)G6-C7-T8] d[A15-Gl6-C17-G18-A19]
central segment of the (BP)G-C il-mer duplex are shown in
color in Fig. 4. The BP ring highlighted in yellow is positioned
in the minor groove; its long axis is oriented toward the 5' end
of the modified strand with one face in contact with the
backbone at residues G18 and A19 on the partner strand. The
orientation of the pyrenyl moiety is governed by the two
torsion angles at the carcinogen-base linkage site and the
pucker of the nonplanar ring, which prevents complete burial
in the groove. The torsion angles at the carcinogen-base
linkage as defined in ref. 32 are 1370 for N1-C2-N2-C1O and
258° for C2-N2-ClO-C9 in the (BP)G-C li-mer duplex. The
angle between the long axis of the BP ring and the average
FIG. 4. Four views of the [T4-C5-(BP)G6-C7-T8]H[A15-G16-C17-
G18-A19] segment in the solution structure of the (BP)G-C li-mer
duplex. The BP ring (yellow) is positioned in the minor groove and
its long axis is directed toward the 5' end of the modified strand. The
upper left view emphasizes the 450 inclination between the BP long
axis and the DNA helix axis. The upper right view emphasizes the
stacking of the BP ring over the G18-A19 segment on the unmodified
strand and the exposed nature ofone face ofthe aromatic ring system
of the BP ring. The lower left view is looking into the minor groove.
It also emphasizes the differences between the two faces of the BP
ring; one face forms van der Waals contacts with the G18-A19 step
and the other face is exposed to solvent. The lower right view is down
the helix axis. Only a small segment of the BP ring projects beyond
the DNA helix diameter. The minor groove width can be measured
as the shortest phosphorus-phosphorus separation across the two
strands less the 5.8-A diameter ofeach phosphorus group. The minor
groove width increases on proceeding from the ends of the (BP)G-C
il-mer duplex to the BP adduct site toward the center of the helix.
The separations are 4.3 A for P4-P21 and 4.5 A for P10-P15 toward
either end of the helix and increase to 8.1 A for P7-P18 toward the
center of the helix. (The nomenclature is such that P18 would be the
phosphorus at the A18-G19 step.) HELIB 90, available from R.
Dickerson (University of California at Los Angeles) was employed
to compute these values.
helix axis is -45° in the (BP)G-C 1i-mer duplex. This value
can be compared with angles of 260 (35) and 39° (36) estimated
from flow dichroism studies for the (+)-anti-BPDE adducts
of poly(dG-dC) in solution.
The DNA helix is minimally perturbed by formation of the
(+)-trans-anti-BPDE-N2-dG adduct in the computed struc-
ture of the (BP)G-C li-mer duplex. The base pairs adopt
Watson-Crick alignment including the (BP)G6-C17 pair at the
modification site; all glycosidic torsion angles are in the anti
range (values distributed between -103° and -125°) and all
sugar puckers are in the C2'-endo range (pseudorotation
phase angle values distributed between 141° and 1670). The
backbone torsion angles belong to the BI-DNA family (37)
and the helix remains bent at the adduct site in the computed
structure as it was in the starting structure (32). The average
helical twist angle for the 5 base pairs centered about the
(BP)G6-C17 modification site is 36.3° in the computed struc-
ture of the (BP)G*C li-mer duplex. The minor groove widens
at the adduct site (see Fig. 3) to accommodate the BP ring.
DISCUSSION
Structural Conclusions. The present combined NMR and
energy minimization computational studies provide strong
support for qualitative (38) and quantitative (32) features of
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the minor groove binding model of the (+)-trans-anti-BPDE-
N2-dG adduct positioned opposite dC in duplex DNA. Our
experimental results definitively rule out models that pro-
posed intercalation or wedge-shaped intercalation of the
covalently linked BPDE between base pairs in DNA (39, 40).
Further, our structure of the (BP)G-C i-mer complex that
directs the covalently attached BP ring toward the 5' end in
the minor groove is in agreement with some computational
studies (32, 41) but not with others that direct the ring toward
the 3' end in the minor groove (42-44). Our results differ from
the conclusions of computational studies that proposed that
the (+)-trans-anti-BPDE-N2-dG adduct can only be posi-
tioned in the minor groove ofA-DNA (42, 43) since the DNA
helix was established in this study to be of the B type for the
(BP)G-C i-mer duplex in solution. Further, we find no
evidence for a heterogeneous equilibrium of two different
covalently bound BP adduct conformations (35) for the
(+)-trans-anti-BPDE-N2-dG adduct positioned opposite dC
and flanked by G*C pairs for the (BP)G-C li-mer duplex
reported in this study.
We note several similarities between the present structural
study of the (+)-trans-anti-BPDE-N2-dG adduct positioned
opposite dC in an li-mer duplex and an earlier study of the
anthramycin-N2-dG adduct positioned opposite dC in a 6-mer
duplex (45, 46). In both cases the covalent adduct adopts a
unique alignment in the minor groove with minimal pertur-
bation of the B-DNA helix.
The present study establishes the feasibility of structural
studies of enantiomerically pure BPDE adducts covalently
attached at single sites in DNA. For the (+)-trans-anti-
BPDE-N2-dG adduct positioned opposite dC, the BP is
readily accommodated with minimal perturbation in the
minor groove of B-DNA. Further, one face of the BP is
exposed to solvent and only a small segment of its aromatic
ring projects beyond the DNA helix diameter. Earlier fluo-
rescence studies support partial exposure ofthe BP moiety to
solvent (47). Clearly, other stereoisomers ofBPDE will form
covalent adducts that will exhibit their own characteristic
conformational features. Their structures can also be ap-
proached by the NMR techniques described in this paper
and, if diffracting crystals become available, by x-ray tech-
niques as well. Such comprehensive studies on BP and other
polycyclic aromatic hydrocarbon diol epoxide adducts
should provide the molecular basis for an understanding of a
stereoisomer-dependent spectra of mutagenic and carcino-
genic activities by these extremely important environmental
genotoxins.
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